Table of Contents Author Guidelines Submit a Manuscript
Journal of Drug Delivery
Volume 2012, Article ID 245835, 9 pages
http://dx.doi.org/10.1155/2012/245835
Research Article

Effects of Atelocollagen Formulation Containing Oligonucleotide on Endothelial Permeability

1Formulation Research and Development Laboratories, Dainippon Sumitomo Pharma Co., Ltd., 1-3-45 Kurakakiuchi, Ibaraki-shi, Osaka 567-0878, Japan
2Department of Pathology, Sapporo Medical University School of Medicine, S1, W17, Sapporo 060-8556, Japan
3Environmental Health Science Laboratory, Sumitomo Chemical Co., Ltd., Osaka 554-0022, Japan
4Research Institute, Koken Co., Ltd., 2-13-10, Ukima, Kita-ku, Tokyo 115-0051, Japan

Received 29 August 2011; Revised 11 December 2011; Accepted 12 December 2011

Academic Editor: Rassoul Dinarvand

Copyright © 2012 Koji Hanai et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Koji Hanai, Takashi Kojima, Mika Ota, Jun Onodera, and Norimasa Sawada, “Effects of Atelocollagen Formulation Containing Oligonucleotide on Endothelial Permeability,” Journal of Drug Delivery, vol. 2012, Article ID 245835, 9 pages, 2012. https://doi.org/10.1155/2012/245835.